Home › Focal Segmental Glomerulosclerosis › Minnesota
Pag-aaral pangklinika para sa Focal Segmental Glomerulosclerosis sa Minnesota
5 pag-aaral para sa Focal Segmental Glomerulosclerosis ang naghahanap ng mga kalahok sa mga site sa Minnesota.
Mga Lungsod sa Minnesota
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- InterMed Consultants - Edina Clinic- Site Number : 8400019, Edina
Nagre-recruitPhase 2
Edad 16 hanggang 75 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06500702Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- University of Minnesota, Minneapolis
Nagre-recruit
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT02235857Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of Minnesota, Masonic Children's Hospital, Minneapolis
Nagre-recruitPhase 2
Edad 1 hanggang 17 · Lahat ng kasarian · Na-update May 12, 2026 · NCT05003986SLIT ABS: Study on Patients With Autoimmune Podocytopathy
- Mayo Clinic, Rochester
Nagre-recruit
Edad 0 hanggang 99 · Lahat ng kasarian · Na-update Abr 8, 2026 · NCT07516964A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- University of Minnesota, Minneapolis
Nagre-recruitPhase 3
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Peb 3, 2026 · NCT05183646Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.